Biocept reports 2020 fourth quarter and full year financial results

San diego--(business wire)--biocept, inc. (nasdaq: bioc), a leading provider of molecular diagnostic assays, products and services, reports financial results for the three and 12 months ended december 31, 2020 and provides a business update. “i'm exceptionally proud of the biocept team for their enthusiasm and dedication in supporting the covid-19 testing needs of our community while advancing our oncology business for a strong post-pandemic future,” said michael nall, president and ceo of bioc
BIOC Ratings Summary
BIOC Quant Ranking